Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

[18F]SPA-RQ/PET Study of NK1 receptors in the Whole Body of Guinea Pig and Rat.

Grönroos TJ, Forsback S, Eskola O, Bergman J, Marjamäki P, Löyttyniemi E, Hietala J, Haaparanta-Solin M, Solin O.

Sci Rep. 2019 Dec 31;9(1):20412. doi: 10.1038/s41598-019-56848-3.

2.

The neural and molecular basis of working memory function in psychosis: a multimodal PET-fMRI study.

Borgan F, O'Daly O, Veronese M, Reis Marques T, Laurikainen H, Hietala J, Howes O.

Mol Psychiatry. 2019 Dec 4. doi: 10.1038/s41380-019-0619-6. [Epub ahead of print]

PMID:
31801965
3.

Amygdala subnucleus volumes in psychosis high-risk state and first-episode psychosis.

Armio RL, Laurikainen H, Ilonen T, Walta M, Salokangas RKR, Koutsouleris N, Hietala J, Tuominen L.

Schizophr Res. 2019 Nov 16. pii: S0920-9964(19)30445-1. doi: 10.1016/j.schres.2019.10.014. [Epub ahead of print]

PMID:
31744752
4.

In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis.

Borgan F, Laurikainen H, Veronese M, Marques TR, Haaparanta-Solin M, Solin O, Dahoun T, Rogdaki M, Salokangas RK, Karukivi M, Di Forti M, Turkheimer F, Hietala J, Howes O; METSY Group.

JAMA Psychiatry. 2019 Jul 3. doi: 10.1001/jamapsychiatry.2019.1427. [Epub ahead of print]

5.

Longitudinal brain morphology in anti-NMDA receptor encephalitis: a case report with controls.

Laurikainen H, Isotupa I, Nyman M, Ilonen T, Nummelin T, Salokangas RKR, Hietala J.

BMC Psychiatry. 2019 May 10;19(1):145. doi: 10.1186/s12888-019-2141-4.

6.

A study on the association of psychiatric diagnoses and childhood adversities with suicide risk.

Salokangas RKR, Luutonen S, Heinimaa M, From T, Hietala J.

Nord J Psychiatry. 2019 Feb;73(2):125-131. doi: 10.1080/08039488.2018.1493748. Epub 2019 Mar 11.

PMID:
30856038
7.

Childhood physical abuse and emotional neglect are specifically associated with adult mental disorders.

Salokangas RKR, Schultze-Lutter F, Schmidt SJ, Pesonen H, Luutonen S, Patterson P, Graf von Reventlow H, Heinimaa M, From T, Hietala J.

J Ment Health. 2019 Jan 24:1-9. doi: 10.1080/09638237.2018.1521940. [Epub ahead of print]

PMID:
30675805
8.

Body mass index trajectories in childhood and adolescence - Risk for non-affective psychosis.

Sormunen E, Saarinen MM, Salokangas RKR, Hutri-Kähönen N, Viikari JSA, Raitakari OT, Hietala J.

Schizophr Res. 2019 Apr;206:313-317. doi: 10.1016/j.schres.2018.10.025. Epub 2018 Oct 26.

PMID:
30482644
9.

Sex difference in brain CB1 receptor availability in man.

Laurikainen H, Tuominen L, Tikka M, Merisaari H, Armio RL, Sormunen E, Borgan F, Veronese M, Howes O, Haaparanta-Solin M, Solin O, Hietala J; METSY group.

Neuroimage. 2019 Jan 1;184:834-842. doi: 10.1016/j.neuroimage.2018.10.013. Epub 2018 Oct 5.

PMID:
30296558
10.

Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis.

Koutsouleris N, Kambeitz-Ilankovic L, Ruhrmann S, Rosen M, Ruef A, Dwyer DB, Paolini M, Chisholm K, Kambeitz J, Haidl T, Schmidt A, Gillam J, Schultze-Lutter F, Falkai P, Reiser M, Riecher-Rössler A, Upthegrove R, Hietala J, Salokangas RKR, Pantelis C, Meisenzahl E, Wood SJ, Beque D, Brambilla P, Borgwardt S; PRONIA Consortium.

JAMA Psychiatry. 2018 Nov 1;75(11):1156-1172. doi: 10.1001/jamapsychiatry.2018.2165. Erratum in: JAMA Psychiatry. 2019 May 1;76(5):550.

11.

Brain neurokinin-1 receptor availability in never-medicated patients with major depression - A pilot study.

Nyman M, Eskola O, Kajander J, Jokinen R, Penttinen J, Karjalainen T, Nummenmaa L, Hirvonen J, Burns D, Hargreaves R, Solin O, Hietala J.

J Affect Disord. 2019 Jan 1;242:188-194. doi: 10.1016/j.jad.2018.08.084. Epub 2018 Aug 25.

PMID:
30193189
12.

Adverse childhood experiences leads to perceived negative attitude of others and the effect of adverse childhood experiences on depression in adulthood is mediated via negative attitude of others.

Salokangas RKR, From T, Luutonen S, Hietala J.

Eur Psychiatry. 2018 Oct;54:27-34. doi: 10.1016/j.eurpsy.2018.06.011. Epub 2018 Jul 21.

PMID:
30041073
13.

Dopaminergic and serotonergic mechanisms in the modulation of pain: In vivo studies in human brain.

Martikainen IK, Hagelberg N, Jääskeläinen SK, Hietala J, Pertovaara A.

Eur J Pharmacol. 2018 Sep 5;834:337-345. doi: 10.1016/j.ejphar.2018.07.038. Epub 2018 Jul 20. Review.

PMID:
30036531
14.

Childhood adversity predicts persistence of suicidal thoughts differently in females and males at clinical high-risk patients of psychosis. Results of the EPOS project.

Salokangas RKR, Patterson P, Hietala J, Heinimaa M, From T, Ilonen T, von Reventlow HG, Schultze-Lutter F, Juckel G, Linszen D, Dingemans P, Birchwood M, Klosterkötter J, Ruhrmann S; EPOS group.

Early Interv Psychiatry. 2019 Aug;13(4):935-942. doi: 10.1111/eip.12714. Epub 2018 Jul 23.

PMID:
30033690
15.

Effect of childhood adversities on alcohol problems is mainly mediated by depression.

Salokangas RKR, From T, Luutonen S, Salokangas HRW, Hietala J.

Am J Addict. 2018 May 15. doi: 10.1111/ajad.12734. [Epub ahead of print]

PMID:
29766600
16.

Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014.

Kurko T, Saastamoinen LK, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen M, Hietala J.

Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):674-682. doi: 10.1002/pds.4551. Epub 2018 May 4.

PMID:
29726630
17.

Platform for systems medicine research and diagnostic applications in psychotic disorders-The METSY project.

Frank E, Maier D, Pajula J, Suvitaival T, Borgan F, Butz-Ostendorf M, Fischer A, Hietala J, Howes O, Hyötyläinen T, Janssen J, Laurikainen H, Moreno C, Suvisaari J, Van Gils M, Orešič M.

Eur Psychiatry. 2018 Apr;50:40-46. doi: 10.1016/j.eurpsy.2017.12.001. Epub 2018 Feb 1. Review.

PMID:
29361398
18.

Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females.

Tuominen L, Miettunen J, Cannon DM, Drevets WC, Frokjaer VG, Hirvonen J, Ichise M, Jensen PS, Keltikangas-Järvinen L, Klaver JM, Knudsen GM, Takano A, Suhara T, Hietala J.

Int J Neuropsychopharmacol. 2017 Dec 1;20(12):963-970. doi: 10.1093/ijnp/pyx071.

19.

Effects of childhood and adolescence physical activity patterns on psychosis risk-a general population cohort study.

Sormunen E, Saarinen MM, Salokangas RKR, Telama R, Hutri-Kähönen N, Tammelin T, Viikari J, Raitakari O, Hietala J.

NPJ Schizophr. 2017 Jan 13;3:5. doi: 10.1038/s41537-016-0007-z. eCollection 2017.

20.

Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids.

Lamusuo S, Hirvonen J, Lindholm P, Martikainen IK, Hagelberg N, Parkkola R, Taiminen T, Hietala J, Helin S, Virtanen A, Pertovaara A, Jääskeläinen SK.

Eur J Pain. 2017 Oct;21(9):1505-1515. doi: 10.1002/ejp.1052. Epub 2017 May 11.

PMID:
28493519
21.

Verbal memory and 5-HT1A receptors in healthy volunteers--A PET study with [carbonyl-(11)C]WAY-100635.

Penttilä J, Hirvonen J, Tuominen L, Lumme V, Ilonen T, Någren K, Hietala J.

Eur Neuropsychopharmacol. 2016 Mar;26(3):570-7. doi: 10.1016/j.euroneuro.2015.12.028. Epub 2015 Dec 21.

PMID:
26775837
22.

[Research has changed our view about psychoses].

Hietala J, Heinimaa M, Suvisaari J.

Duodecim. 2015;131(22):2117-24. Review. Finnish.

PMID:
26749905
23.

Depression predicts persistence of paranoia in clinical high-risk patients to psychosis: results of the EPOS project.

Salokangas RK, Schultze-Lutter F, Hietala J, Heinimaa M, From T, Ilonen T, Löyttyniemi E, von Reventlow HG, Juckel G, Linszen D, Dingemans P, Birchwood M, Patterson P, Klosterkötter J, Ruhrmann S; EPOS Group.

Soc Psychiatry Psychiatr Epidemiol. 2016 Feb;51(2):247-57. doi: 10.1007/s00127-015-1160-9. Epub 2015 Dec 7.

PMID:
26643940
24.

Author reply to: "Depressive symptomatology, serotonergic activity, and neuroticism: A methodological recommendation".

Hirvonen J, Tuominen L, Hietala J, Någren K.

Psychiatry Res. 2015 Dec 30;234(3):391. doi: 10.1016/j.pscychresns.2015.10.015. Epub 2015 Oct 28. No abstract available.

PMID:
26603911
25.

Long-term use of benzodiazepines: Definitions, prevalence and usage patterns - a systematic review of register-based studies.

Kurko TA, Saastamoinen LK, Tähkäpää S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen MS, Hietala J.

Eur Psychiatry. 2015 Nov;30(8):1037-47. doi: 10.1016/j.eurpsy.2015.09.003. Epub 2015 Nov 4. Review.

PMID:
26545257
26.

The Cannabinoid Receptor-1 Is an Imaging Biomarker of Brown Adipose Tissue.

Eriksson O, Mikkola K, Espes D, Tuominen L, Virtanen K, Forsbäck S, Haaparanta-Solin M, Hietala J, Solin O, Nuutila P.

J Nucl Med. 2015 Dec;56(12):1937-41. doi: 10.2967/jnumed.115.156422. Epub 2015 Sep 10.

27.

Neuroticism and serotonin 5-HT1A receptors in healthy subjects.

Hirvonen J, Tuominen L, Någren K, Hietala J.

Psychiatry Res. 2015 Oct 30;234(1):1-6. doi: 10.1016/j.pscychresns.2015.04.007. Epub 2015 May 2.

PMID:
26337006
28.

Aberrant mesolimbic dopamine-opiate interaction in obesity.

Tuominen L, Tuulari J, Karlsson H, Hirvonen J, Helin S, Salminen P, Parkkola R, Hietala J, Nuutila P, Nummenmaa L.

Neuroimage. 2015 Nov 15;122:80-6. doi: 10.1016/j.neuroimage.2015.08.001. Epub 2015 Aug 7.

PMID:
26260431
29.

Right secondary somatosensory cortex-a promising novel target for the treatment of drug-resistant neuropathic orofacial pain with repetitive transcranial magnetic stimulation.

Lindholm P, Lamusuo S, Taiminen T, Pesonen U, Lahti A, Virtanen A, Forssell H, Hietala J, Hagelberg N, Pertovaara A, Parkkola R, Jääskeläinen S.

Pain. 2015 Jul;156(7):1276-83. doi: 10.1097/j.pain.0000000000000175.

PMID:
25830924
30.

Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation.

Jääskeläinen SK, Lindholm P, Valmunen T, Pesonen U, Taiminen T, Virtanen A, Lamusuo S, Forssell H, Hagelberg N, Hietala J, Pertovaara A.

Pain. 2014 Oct;155(10):2180-7. doi: 10.1016/j.pain.2014.08.029. Epub 2014 Aug 29.

PMID:
25180011
31.

DRD2-related TaqIA genotype is associated with dopamine release during a gambling task.

Joutsa J, Hirvonen MM, Arponen E, Hietala J, Kaasinen V.

J Addict Med. 2014 Jul-Aug;8(4):294-5. doi: 10.1097/ADM.0000000000000037. No abstract available.

PMID:
25089954
32.

Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project.

Salokangas RK, Heinimaa M, From T, Löyttyniemi E, Ilonen T, Luutonen S, Hietala J, Svirskis T, von Reventlow HG, Juckel G, Linszen D, Dingemans P, Birchwood M, Patterson P, Schultze-Lutter F, Ruhrmann S, Klosterkötter J; EPOS group.

Eur Psychiatry. 2014 Aug;29(6):371-80. doi: 10.1016/j.eurpsy.2013.10.003. Epub 2013 Dec 7.

PMID:
24315804
33.

Increased serotonin receptor 1A binding in major depressive disorder after psychotherapy, but not after SSRI pharmacotherapy, is related to improved social functioning capacity.

Karlsson H, Hirvonen J, Salminen J, Hietala J.

Psychother Psychosom. 2013;82(4):260-1. doi: 10.1159/000346143. Epub 2013 Jun 1. No abstract available.

PMID:
23736831
34.

Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems.

Tuominen L, Nummenmaa L, Keltikangas-Järvinen L, Raitakari O, Hietala J.

Hum Brain Mapp. 2014 May;35(5):1875-84. doi: 10.1002/hbm.22298. Epub 2013 May 14.

PMID:
23671038
35.

First measurement of the form factors in the decays D0 → ρ- e+ ν(e) and D+ → ρ0 e+ ν(e).

Dobbs S, Metreveli Z, Seth KK, Tomaradze A, Xiao T, Martin L, Powell A, Wilkinson G, Mendez H, Asner DM, Tatishvili G, Ge JY, Huang GS, Miller DH, Pavlunin V, Shipsey IP, Xin B, Adams GS, Hu D, Moziak B, Napolitano J, Ecklund KM, Insler J, Muramatsu H, Park CS, Pearson LJ, Thorndike EH, Ricciardi S, Thomas C, Artuso M, Blusk S, Mountain R, Skwarnicki T, Stone S, Zhang LM, Bonvicini G, Cinabro D, Lincoln A, Smith MJ, Zhou P, Zhu J, Naik P, Rademacker J, Edwards KW, Randrianarivony K, Briere RA, Vogel H, Onyisi PU, Rosner JL, Alexander JP, Cassel DG, Das S, Ehrlich R, Gibbons L, Gray SW, Hartill DL, Heltsley BK, Kreinick DL, Kuznetsov VE, Patterson JR, Peterson D, Riley D, Ryd A, Sadoff AJ, Shi X, Sun WM, Yelton J, Rubin P, Lowrey N, Mehrabyan S, Selen M, Wiss J, Libby J, Kornicer M, Mitchell RE, Tarbert CM, Besson D, Pedlar TK, Cronin-Hennessy D, Hietala J; CLEO Collaboration.

Phys Rev Lett. 2013 Mar 29;110(13):131802. Epub 2013 Mar 26.

PMID:
23581310
36.

Serotonin transporter in attention-deficit hyperactivity disorder--preliminary results from a positron emission tomography study.

Karlsson L, Tuominen L, Huotarinen A, Leppämäki S, Sihvola E, Helin S, Sipilä M, Tani P, Hirvonen J, Hietala J, Karlsson H.

Psychiatry Res. 2013 May 30;212(2):164-5. doi: 10.1016/j.pscychresns.2013.02.001. Epub 2013 Apr 6.

PMID:
23566552
37.

Prediction of psychosis in clinical high-risk patients by the Schizotypal Personality Questionnaire. Results of the EPOS project.

Salokangas RK, Dingemans P, Heinimaa M, Svirskis T, Luutonen S, Hietala J, Ruhrmann S, Juckel G, Graf von Reventlow H, Linszen D, Birchwood M, Patterson P, Schultze-Lutter F, Klosterkötter J; EPOS group.

Eur Psychiatry. 2013 Oct;28(8):469-75. doi: 10.1016/j.eurpsy.2013.01.001. Epub 2013 Feb 8.

PMID:
23394823
38.

Automatic statistical shape analysis of cerebral asymmetry in 3D T1-weighted magnetic resonance images at vertex-level: application to neuroleptic-naïve schizophrenia.

Pepe A, Zhao L, Koikkalainen J, Hietala J, Ruotsalainen U, Tohka J.

Magn Reson Imaging. 2013 Jun;31(5):676-87. doi: 10.1016/j.mri.2012.10.021. Epub 2013 Jan 20.

PMID:
23337078
39.

Temperament, character and serotonin activity in the human brain: a positron emission tomography study based on a general population cohort.

Tuominen L, Salo J, Hirvonen J, Någren K, Laine P, Melartin T, Isometsä E, Viikari J, Cloninger CR, Raitakari O, Hietala J, Keltikangas-Järvinen L.

Psychol Med. 2013 Apr;43(4):881-94. doi: 10.1017/S003329171200164X. Epub 2012 Jul 31.

PMID:
22850434
40.

Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.

Hagelberg N, Aalto S, Tuominen L, Pesonen U, Någren K, Hietala J, Scheinin H, Pertovaara A, Martikainen IK.

Neurosci Lett. 2012 Jul 11;521(1):11-4. doi: 10.1016/j.neulet.2012.05.042. Epub 2012 May 20.

PMID:
22622175
41.

Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: a PET study using [(11)C]carfentanil.

Tuominen L, Salo J, Hirvonen J, Någren K, Laine P, Melartin T, Isometsä E, Viikari J, Raitakari O, Keltikangas-Järvinen L, Hietala J.

Neuroimage. 2012 Jul 2;61(3):670-6. doi: 10.1016/j.neuroimage.2012.03.063. Epub 2012 Mar 29.

PMID:
22484309
42.

Lack of efficacy of L-759274, a novel neurokinin 1 (substance P) receptor antagonist, for the treatment of generalized anxiety disorder.

Michelson D, Hargreaves R, Alexander R, Ceesay P, Hietala J, Lines C, Reines S.

Int J Neuropsychopharmacol. 2013 Feb;16(1):1-11. doi: 10.1017/S1461145712000065. Epub 2012 Mar 20.

PMID:
22433185
43.

Mesolimbic dopamine release is linked to symptom severity in pathological gambling.

Joutsa J, Johansson J, Niemelä S, Ollikainen A, Hirvonen MM, Piepponen P, Arponen E, Alho H, Voon V, Rinne JO, Hietala J, Kaasinen V.

Neuroimage. 2012 May 1;60(4):1992-9. doi: 10.1016/j.neuroimage.2012.02.006. Epub 2012 Feb 14.

PMID:
22348881
44.

Observation of the h(c)(1P) Using e+ e- collisions above the DD threshold.

Pedlar TK, Cronin-Hennessy D, Hietala J, Dobbs S, Metreveli Z, Seth KK, Tomaradze A, Xiao T, Martin L, Powell A, Wilkinson G, Mendez H, Ge JY, Miller DH, Shipsey IP, Xin B, Adams GS, Hu D, Moziak B, Napolitano J, Ecklund KM, Insler J, Muramatsu H, Park CS, Pearson LJ, Thorndike EH, Ricciardi S, Thomas C, Artuso M, Blusk S, Mountain R, Skwarnicki T, Stone S, Zhang LM, Bonvicini G, Cinabro D, Lincoln A, Smith MJ, Zhou P, Zhu J, Naik P, Rademacker J, Asner DM, Edwards KW, Randrianarivony K, Tatishvili G, Briere RA, Vogel H, Onyisi PU, Rosner JL, Alexander JP, Cassel DG, Das S, Ehrlich R, Gibbons L, Gray SW, Hartill DL, Heltsley BK, Kreinick DL, Kuznetsov VE, Patterson JR, Peterson D, Riley D, Ryd A, Sadoff AJ, Shi X, Sun WM, Yelton J, Rubin P, Lowrey N, Mehrabyan S, Selen M, Wiss J, Libby J, Kornicer M, Mitchell RE, Shepherd MR, Tarbert CM, Besson D; CLEO Collaboration.

Phys Rev Lett. 2011 Jul 22;107(4):041803. Epub 2011 Jul 20.

PMID:
21866994
45.

Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: a voxel-based meta-analysis of functional magnetic resonance imaging studies.

Delvecchio G, Fossati P, Boyer P, Brambilla P, Falkai P, Gruber O, Hietala J, Lawrie SM, Martinot JL, McIntosh AM, Meisenzahl E, Frangou S.

Eur Neuropsychopharmacol. 2012 Feb;22(2):100-13. doi: 10.1016/j.euroneuro.2011.07.003. Epub 2011 Aug 5. Review.

PMID:
21820878
46.

Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems.

Hirvonen J, Hietala J.

CNS Neurosci Ther. 2011 Apr;17(2):89-96. doi: 10.1111/j.1755-5949.2010.00223.x. Epub 2010 Dec 28. Review.

47.

Gender differences in brain serotonin transporter availability in panic disorder.

Maron E, Tõru I, Hirvonen J, Tuominen L, Lumme V, Vasar V, Shlik J, Nutt DJ, Helin S, Någren K, Tiihonen J, Hietala J.

J Psychopharmacol. 2011 Jul;25(7):952-9. doi: 10.1177/0269881110389207. Epub 2010 Dec 8.

PMID:
21148024
48.

Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C]raclopride PET.

Hirvonen J, Hietala J, Kajander J, Markkula J, Rasi-Hakala H, Salminen JK, Någren K, Aalto S, Karlsson H.

J Psychopharmacol. 2011 Oct;25(10):1329-36. doi: 10.1177/0269881110376691. Epub 2010 Sep 9.

PMID:
20829308
49.

Personality traits and recovery from major depressive disorder.

Kronström K, Salminen JK, Hietala J, Kajander J, Vahlberg T, Markkula J, Rasi-Hakala H, Karlsson H.

Nord J Psychiatry. 2011 Feb;65(1):52-7. doi: 10.3109/08039488.2010.487571. Epub 2010 May 26.

PMID:
20500120
50.

Automatic cerebral and cerebellar hemisphere segmentation in 3D MRI: adaptive disconnection algorithm.

Zhao L, Ruotsalainen U, Hirvonen J, Hietala J, Tohka J.

Med Image Anal. 2010 Jun;14(3):360-72. doi: 10.1016/j.media.2010.02.001. Epub 2010 Feb 10.

PMID:
20303318

Supplemental Content

Loading ...
Support Center